Abhorring the vacuum: use of Alzheimer’s disease medications in frontotemporal dementia.
about
Progressive Supranuclear Palsy and Corticobasal Degeneration: Pathophysiology and Treatment OptionsDifferentiating between visual hallucination-free dementia with Lewy bodies and corticobasal syndrome on the basis of neuropsychology and perfusion single-photon emission computed tomographyCharacteristics of patients misdiagnosed with Alzheimer's disease and their medication use: an analysis of the NACC-UDS database.Diagnosis and management of behavioral issues in frontotemporal dementiaTen common questions (and their answers) about off-label drug use.Demographic and neuropsychiatric factors associated with off-label medication use in frontotemporal dementia and Alzheimer's disease.Dementia Coding, Workup, and Treatment in the VA New England Healthcare System.Schizophrenia and frontotemporal dementia: shared causation?A Systematic Review of Metacognitive Differences Between Alzheimer's Disease and Frontotemporal Dementia.Recent advances in the molecular genetics of frontotemporal lobar degeneration.Pharmacological Management of Psychiatric Symptoms in Frontotemporal Dementia: A Systematic Review.Determining the impact of psychosis on rates of false-positive and false-negative diagnosis in Alzheimer's disease.Behavioral disturbance in dementia.Pharmacotherapy for Dementia: A Practical Approach to the Use of Cholinesterase Inhibitors and Memantine.Donepezil for Compulsive Behavior in Degenerative Dementia: Case Series.Understanding and living with primary progressive aphasia: Current progress and challenges for the future
P2860
Q28072101-AF127589-83C3-4928-81AA-99A68CBFF207Q34636958-29059A37-2A22-4726-8A95-757F61E42D66Q35071880-AF2B7F8D-30CB-4C40-96FE-BAC8D02C05E6Q36238717-AD3B7AA8-B62D-458E-9BBB-66583DF9C135Q36512832-AA74CAED-A370-47E0-BE48-A0F222146595Q37610784-33FC1ABD-5646-4945-8BDF-16661F77337CQ37632067-6AEDE7EA-E86D-4999-9A81-9BFABAD0E1A3Q38101087-68D22D83-30EC-44D1-88AA-3E2DC3BF3198Q38679800-8F4BDAB5-E419-4D5E-A3FF-ADFFBC45D2B8Q38734630-6B3EB4C8-AF6A-49C5-BA60-1C676B0AB964Q38738414-E704DCD4-4612-4633-ADC2-7B3F9962CF1AQ42655543-02A03FA9-FBE1-4B0A-BDDF-21DFB4EB6070Q48241784-6A6F10AA-5E13-4099-905D-914F938881B2Q53377510-EABE949C-B9CB-484E-9017-4EAC1097ABF1Q55343407-BB106258-DD2F-4548-B80F-DF35D1C597F8Q58277104-D42B713B-9922-4F2D-915E-99019D9D09B5
P2860
Abhorring the vacuum: use of Alzheimer’s disease medications in frontotemporal dementia.
description
2011 nî lūn-bûn
@nan
2011 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Abhorring the vacuum: use of Alzheimer’s disease medications in frontotemporal dementia.
@ast
Abhorring the vacuum: use of Alzheimer’s disease medications in frontotemporal dementia.
@en
type
label
Abhorring the vacuum: use of Alzheimer’s disease medications in frontotemporal dementia.
@ast
Abhorring the vacuum: use of Alzheimer’s disease medications in frontotemporal dementia.
@en
prefLabel
Abhorring the vacuum: use of Alzheimer’s disease medications in frontotemporal dementia.
@ast
Abhorring the vacuum: use of Alzheimer’s disease medications in frontotemporal dementia.
@en
P2860
P356
P1476
Abhorring the vacuum: use of Alzheimer’s disease medications in frontotemporal dementia.
@en
P2093
Geoffrey A Kerchner
Maria Carmela Tartaglia
P2860
P304
P356
10.1586/ERN.11.6
P50
P577
2011-05-01T00:00:00Z